Decisions to limit or withdraw treatment in young adults with melanoma

Abstract

melanoma reaches the highest mortality rate by cancer among young men (ages 20-34) in France (1). A recent study suggests that age does not affect survival in patients with advanced disease (3). The prognosis of patients with metastatic or stage IV melanoma is grim, with a 1-year survival rate of 25% and a median overall survival of 6.2 months (2).

This article is protected by copyright. All rights reserved.

http://ift.tt/2rQnyNH